Pratik Shah's most recent trade in ARS Pharmaceuticals Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 25, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ARS Pharmaceuticals Inc | Pratik Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
Design Therapeutics Inc | Pratik Shah | Director, President, CEO and Chairperson | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 600,000 | 600,000 | - | - | Stock option (right to buy) | |
ARS Pharmaceuticals Inc | Pratik Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
ARS Pharmaceuticals Inc | Pratik Shah | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Jun 2024 | 1,132,900 | 0 | - | 0 | Common Stock | |
ARS Pharmaceuticals Inc | Pratik Shah | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Jun 2024 | 200,000 | 1,132,900 | - | 0 | Common Stock | |
ARS Pharmaceuticals Inc | Pratik Shah | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2024 | 1,332,950 | 4,824,554 | - | 0 | Common Stock | |
ARS Pharmaceuticals Inc | Pratik Shah | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 04 Jun 2024 | 2,665,800 | 7,490,404 | - | - | Common Stock | |
ARS Pharmaceuticals Inc | Pratik Shah | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 04 Jun 2024 | 2,665,800 | 7,490,404 | - | - | Common Stock | |
ARS Pharmaceuticals Inc | Pratik Shah | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2024 | 1,332,900 | 6,157,504 | - | 0 | Common Stock | |
ARS Pharmaceuticals Inc | Pratik Shah | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2024 | 1,332,900 | 1,332,900 | - | 0 | Common Stock | |
ARS Pharmaceuticals Inc | Pratik Shah | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
Design Therapeutics Inc | Pratik Shah | Director, Executive Chairperson | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 415,000 | 415,000 | - | - | Stock Option (right to buy) | |
ARS Pharmaceuticals Inc | Pratik Shah | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 10,156,204 | 10,156,204 | - | - | Common Stock | |
ARS Pharmaceuticals Inc | Pratik Shah | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 354,570 | 354,570 | - | - | Employee Stock Option (right to buy) | |
Design Therapeutics Inc | Pratik Shah | Director, Executive Chairperson | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 475,000 | 475,000 | - | - | Stock Option (right to buy) | |
Design Therapeutics Inc | Pratik Shah | Director, Executive Chairperson | 30 Mar 2021 | 171,025 | 0 | - | - | Series A Preferred Stock | ||
Design Therapeutics Inc | Pratik Shah | Director, Executive Chairperson | 30 Mar 2021 | 104,923 | 129,923 | - | - | Common Stock | ||
Design Therapeutics Inc | Pratik Shah | Director, Executive Chairperson | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 30 Mar 2021 | 25,000 | 25,000 | - | 20 | 500,000 | Common Stock |